Aditxt to Participate in the 2022 Virtual Growth Conference
March 23 2022 - 8:30AM
Business Wire
Presented by Maxim Group LLC and Hosted by
M-Vest on March 28th - 30th from 9:00 a.m. - 5:00 p.m. EDT
Aditxt, Inc. (Nasdaq: ADTX), a biotech innovation company
developing technologies focused on mapping and reprogramming the
immune system, announced today that Company CEO & Co-Founder,
Amro Albanna, has been invited to present at the 2022 Virtual
Growth Conference, presented by Maxim Group LLC and hosted by
M-Vest, on March 28th - 30th from 9:00 a.m. - 5:00 p.m. EDT.
https://m-vest.com/events/2022-virtual-growth-conference/p/adtx
Sign up here to access the presentation
During this virtual conference, investors will hear from
executives from a wide range of sectors including Biotech, Clean
Energy, Electric Vehicles, Financial Services, Fintech & REITS,
Gaming & Entertainment, Healthcare, Healthcare IT,
Infrastructure, Shipping and Technology/ Media/Telecom. The
conference will feature company presentations, fireside chats,
roundtable discussions, and live Q&A with CEOs moderated by
Maxim Research Analysts.
This conference will be live on M-Vest. To attend, just sign up
to become an M-Vest member.
Click Here to Reserve your seat
About Aditxt
Aditxt is a biotech innovation company developing technologies
focused on mapping and reprogramming the immune system. Aditxt’s
immune mapping technologies are designed to provide a personalized
immune profile. Aditxt’s immune reprogramming technologies,
currently preclinical, are being developed to retrain the immune
system to induce tolerance to address rejection of transplanted
organs, autoimmune diseases, and allergies.
For more information, please visit: www.aditxt.com and
www.AditxtScore.com
Forward-looking statements
Certain statements in this press release constitute
“forward-looking statements” within the meaning of federal
securities laws. Forward-looking statements include statements
regarding the Company’s intentions, beliefs, projections, outlook,
analyses, or current expectations concerning, among other things,
the Company’s ongoing and planned product and business development;
the Company’s intellectual property position; the Company’s ability
to develop commercial functions; expectations regarding product
launch and revenue; the Company’s results of operations, cash
needs, spending, financial condition, liquidity, prospects, growth
and strategies; the industry in which the Company operates; and the
trends that may affect the industry or the Company. Forward-looking
statements are not guarantees of future performance, and actual
results may differ materially from those indicated by these
forward-looking statements as a result of various important
factors, as well as those risks more fully discussed in the section
titled “Risk Factors” in the Company’s most recent Annual Report on
Form 10-K, as well as discussions of potential risks,
uncertainties, and other important factors in the Company’s other
filings with the Securities and Exchange Commission. All such
statements speak only as of the date made. The Company undertakes
no obligation to update or revise publicly any forward-looking
statements, whether as a result of new information, future events
or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220323005352/en/
Media and investor relations contact Aditxt Investor
Communications ir@aditxt.com www.aditxt.com
Aditxt (NASDAQ:ADTX)
Historical Stock Chart
From May 2024 to Jun 2024
Aditxt (NASDAQ:ADTX)
Historical Stock Chart
From Jun 2023 to Jun 2024